Literature DB >> 25023586

Dilated intercellular spaces in eosinophilic esophagitis.

Alberto Ravelli1, Vincenzo Villanacci, Moris Cadei, Maurizio Fuoti, Giada Gennati, Marianna Salemme.   

Abstract

OBJECTIVES: Dilated intercellular spaces (DIS) in the esophageal epithelium can be induced by acid and reduced by proton pump inhibitors (PPI), and are thus considered a marker of gastroesophageal reflux disease (GERD). Over the years, however, DIS have also been reported in esophagitis unrelated to GERD. Because DIS have never been formally measured in eosinophilic esophagitis (EoE), we aimed at detecting and measuring DIS in EoE before and after nutritional or pharmacological therapy.
METHODS: In 22 children with EoE, DIS were measured by morphometry and transmission electron microscopy (TEM), before and after treatment with topical steroids (n = 16) and/or exclusion diet (n = 13). A total of 30 children undergoing upper gastrointestinal endoscopy with biopsy for nonesophageal disorders acted as controls.
RESULTS: In controls, the mean (± standard deviation [SD]) number of esophageal eosinophils was 0.91 (± 0.47) and the mean DIS values were 0.62 (± 0.08) μm at morphometry and 0.33 (± 0.24) μm at TEM. In patients with EoE, the mean (± SD) number of esophageal eosinophils decreased from 31.8 (± 6.96) to 6.64 (± 5.01) (P < 0.0001), and the mean DIS values decreased from 2.26 (± 0.21) to 1.23 (± 0.20) μm at morphometry (P < 0.0001), and from 2.24 (± 0.28) to 0.98 (± 0.19) μm at TEM (P < 0.0001), respectively, before and after treatment.
CONCLUSIONS: DIS are a prominent morphological feature of EoE, in which they can be significantly reduced by an appropriate non-PPI therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25023586     DOI: 10.1097/MPG.0000000000000491

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  15 in total

1.  Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.

Authors:  Mark Rochman; Jared Travers; Cora E Miracle; Mary C Bedard; Ting Wen; Nurit P Azouz; Julie M Caldwell; Kiran Kc; Joseph D Sherrill; Benjamin P Davis; Jeffrey K Rymer; Kenneth M Kaufman; Bruce J Aronow; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-01-17       Impact factor: 10.793

2.  Epithelial acid imbalance in patients with eosinophilic esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  J Allergy Clin Immunol       Date:  2018-10-10       Impact factor: 10.793

Review 3.  Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies.

Authors:  Leila Kia; Ikuo Hirano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-19       Impact factor: 46.802

Review 4.  Mean nocturnal baseline impedance and endoscopic mucosal impedance measurements in patients with eosinophilic esophagitis: a new tool for follow up and management?

Authors:  Sergeev Ilia; Velosa Monica; Sifrim Daniel
Journal:  Updates Surg       Date:  2022-07-15

Review 5.  Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.

Authors:  Dilawar Khokhar; Sahiti Marella; Gila Idelman; Joy W Chang; Mirna Chehade; Simon P Hogan
Journal:  Clin Exp Allergy       Date:  2022-07-19       Impact factor: 5.401

6.  Development and technical validation of an artificial intelligence model for quantitative analysis of histopathologic features of eosinophilic esophagitis.

Authors:  Luisa Ricaurte Archila; Lindsey Smith; Hanna-Kaisa Sihvo; Thomas Westerling-Bui; Ville Koponen; Donnchadh M O'Sullivan; Maria Camila Cardenas Fernandez; Erin E Alexander; Yaohong Wang; Priyadharshini Sivasubramaniam; Ameya Patil; Puanani E Hopson; Imad Absah; Karthik Ravi; Taofic Mounajjed; Rish Pai; Catherine Hagen; Christopher Hartley; Rondell P Graham; Roger K Moreira
Journal:  J Pathol Inform       Date:  2022-09-27

7.  Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.

Authors:  Chang Zeng; Simone Vanoni; David Wu; Julie M Caldwell; Justin C Wheeler; Kavisha Arora; Taeko K Noah; Lisa Waggoner; John A Besse; Amnah N Yamani; Jazib Uddin; Mark Rochman; Ting Wen; Mirna Chehade; Margaret H Collins; Vincent A Mukkada; Philip E Putnam; Anjaparavanda P Naren; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

Review 8.  EoE disease monitoring: Where we are and where we are going.

Authors:  Bridget Godwin; Benjamin Wilkins; Amanda B Muir
Journal:  Ann Allergy Asthma Immunol       Date:  2019-12-09       Impact factor: 6.347

9.  TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis.

Authors:  N Nguyen; S D Fernando; K A Biette; J A Hammer; K E Capocelli; D A Kitzenberg; L E Glover; S P Colgan; G T Furuta; J C Masterson
Journal:  Mucosal Immunol       Date:  2017-08-23       Impact factor: 7.313

10.  Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.

Authors:  Benjamin L Wright; Nielsen Q Fernandez-Becker; Neeraja Kambham; Natasha Purington; Shu Cao; Dana Tupa; Wenming Zhang; Sayantani B Sindher; Matthew A Rank; Hirohito Kita; David A Katzka; Kelly P Shim; Bryan J Bunning; Alfred D Doyle; Elizabeth A Jacobsen; Mindy Tsai; Scott D Boyd; Monali Manohar; R Sharon Chinthrajah
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-17       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.